Stay updated on ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.

Latest updates to the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Naples, Campania, Italy, 80131 and removed Napoli, Campania, Italy, 80131.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 (page revision metadata).SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now displays Revision 3.4.3, replacing Revision 3.4.2.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded VERITAC-3 study details including design, SLI and Phase 3 plan, enrollment targets, endpoints, and participating locations. Removed outdated notices about funding and prior version text.SummaryDifference1%

- Check62 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status, with links to cc.nih.gov and opm.gov for updates. Updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check69 days agoChange DetectedThe page now includes a Show glossary option and updated metadata: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 have been removed.SummaryDifference0.2%

Stay in the know with updates to ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.